Haemonetics Corp. (HAE)
118.69
-0.78
(-0.65%)
USD |
NYSE |
Oct 09, 16:00
118.73
+0.04
(+0.03%)
Pre-Market: 20:00
Haemonetics Free Cash Flow : 291.22M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 291.22M |
| March 31, 2026 | 260.44M |
| December 31, 2025 | 308.08M |
| September 30, 2025 | 256.08M |
| June 30, 2025 | 189.16M |
| March 31, 2025 | 142.45M |
| December 31, 2024 | 95.93M |
| September 30, 2024 | 37.88M |
| June 30, 2024 | 72.96M |
| March 31, 2024 | 115.46M |
| December 31, 2023 | 127.63M |
| September 30, 2023 | 198.03M |
| June 30, 2023 | 174.65M |
| March 31, 2023 | 161.75M |
| December 31, 2022 | 128.11M |
| September 30, 2022 | 116.31M |
| June 30, 2022 | 87.88M |
| March 31, 2022 | 75.75M |
| December 31, 2021 | 32.73M |
| September 30, 2021 | 53.88M |
| June 30, 2021 | 52.05M |
| March 31, 2021 | 71.76M |
| December 31, 2020 | 117.61M |
| September 30, 2020 | 119.58M |
| June 30, 2020 | 119.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 109.46M |
| December 31, 2019 | 80.62M |
| September 30, 2019 | 50.65M |
| June 30, 2019 | 39.09M |
| March 31, 2019 | 40.32M |
| December 31, 2018 | 71.92M |
| September 30, 2018 | 81.82M |
| June 30, 2018 | 116.46M |
| March 31, 2018 | 145.55M |
| December 31, 2017 | 125.99M |
| September 30, 2017 | 123.47M |
| June 30, 2017 | 100.09M |
| March 31, 2017 | 83.60M |
| December 31, 2016 | 89.36M |
| September 30, 2016 | 61.16M |
| June 30, 2016 | 42.67M |
| March 31, 2016 | 19.46M |
| December 31, 2015 | 28.36M |
| September 30, 2015 | 17.48M |
| June 30, 2015 | 13.31M |
| March 31, 2015 | 4.958M |
| December 31, 2014 | -7.113M |
| September 30, 2014 | 25.42M |
| June 30, 2014 | 42.22M |
| March 31, 2014 | 65.88M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ICU Medical, Inc. | 144.84M |
| Merit Medical Systems, Inc. | 199.76M |
| Teleflex, Inc. | 339.77M |
| Globus Medical, Inc. | 750.84M |
| Abbott Laboratories | 7.824B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 52.32M |
| Cash from Investing (Quarterly) | -22.23M |
| Cash from Financing (Quarterly) | -51.53M |
| Free Cash Flow Per Share (Quarterly) | 0.9718 |
| Free Cash Flow to Equity (Quarterly) | 144.98M |
| Free Cash Flow to Firm (Quarterly) | 51.47M |
| Free Cash Flow Yield | 5.26% |